Economic benefits of treating medication-overuse headache – results from the multicenter COMOESTAS project
- 8 July 2018
- journal article
- research article
- Published by SAGE Publications in Cephalalgia
- Vol. 39 (2) , 274-285
Abstract
Medication-overuse headache is a costly disease for individuals and society. To estimate the impact of medication-overuse headache treatment on direct and indirect headache-related health care costs. This prospective longitudinal study was part of the COMOESTAS project (COntinuous MOnitoring of Medication Overuse Headache in Europe and Latin America: development and STAndardization of an Alert and decision support System). Patients with medication-overuse headache were included from four European and two Latin American headache centers. Costs of acute medication, costs of health care services, and measurements of productivity were calculated at baseline and at 6-month follow-up Treatment consisted of overused drug withdrawal with optional preventive medication. A total of 475 patients (71%) completed treatment and were followed up for 6 months. Direct health care costs were on average reduced significantly by 52% (p < 0.001) for the total study population. Significant reductions were seen in both number of consumed tablets (−71%, p < 0.001) and number of visits to physicians (−43%, p < 0.001). Fifty percent of patients reduced their number of consumed tablets ≥ 80%. Headache-related productivity loss, calculated either as absence from work or ≥ 50% reduction of productivity during the workday, were reduced by 21% and 34%, respectively (p < 0.001). Standardized treatment of medication-overuse headache in six countries significantly reduced direct health care costs and increased productivity. This emphasizes the importance of increasing awareness of the value of treating medication-overuse headache. The trial was registered at ClinicalTrials.gov (no. NCT02435056)Keywords
Funding Information
- COMOESTAS project (EC contract number 215366 (COMOESTAS) FP7)
This publication has 30 references indexed in Scilit:
- Prevention and management of medication overuse headacheCurrent Opinion in Neurology, 2012
- Treatment of medication overuse headache - guideline of the EFNS headache panelEuropean Journal of Neurology, 2011
- In-patient versus out-patient withdrawal programmes for medication overuse headache: A 2-year randomized trialCephalalgia, 2011
- Quality of life impairment, disability and economic burden associated with chronic daily headache, focusing on chronic migraine with or without medication overuse: A systematic reviewCephalalgia, 2011
- Clinical features, pathophysiology, and treatment of medication-overuse headacheThe Lancet Neurology, 2010
- Disability in chronic migraine with medication overuse: Treatment effects through 5 yearsCephalalgia, 2009
- Medication Overuse Headache: Clinical Features Predicting Treatment Outcome at 1-Year Follow-UpCephalalgia, 2007
- Advice Alone Vs. Structured Detoxification Programmes for Medication Overuse Headache: A Prospective, Randomized, Open-Label Trial in Transformed Migraine Patients With Low Medical NeedsCephalalgia, 2006
- New Appendix Criteria Open for a Broader Concept of Chronic MigraineCephalalgia, 2006
- Drug-Induced Headache: Long-Term Results of Stationary Versus Ambulatory Withdrawal TherapyCephalalgia, 1999